Similar to TCGA, CDX2-suppressed and non-CDX2-suppressed colon cancers did not differ significantly in their mean age, percentage of patients above 65 years old, or prevalence of metastatic disease (Table 4). The gene discussed is CDX2; the disease is metastatic neoplasm.